These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


61 related items for PubMed ID: 2172032

  • 1. [The role of the thrombocyte-activating factor in the development of circulatory disorders in the postischemic shock reaction].
    Sagach VF, Dmitrieva AV.
    Fiziol Zh (1978); 1990; 36(4):8-14. PubMed ID: 2172032
    [Abstract] [Full Text] [Related]

  • 2. Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).
    Sagach VF, Dmitrieva AV, Braquet P.
    Lipids; 1991 Dec; 26(12):1400-3. PubMed ID: 1819740
    [Abstract] [Full Text] [Related]

  • 3. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
    Filep JG, Braquet P, Mózes T.
    Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
    [Abstract] [Full Text] [Related]

  • 4. [Cardio- and hemodynamics of dogs during the development of postischemic shock reaction].
    Sagach VF, Dmitrieva AV.
    Fiziol Zh (1978); 1989 Sep; 35(4):9-15. PubMed ID: 2792447
    [Abstract] [Full Text] [Related]

  • 5. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence.
    Kubes P, Ibbotson G, Russell J, Wallace JL, Granger DN.
    Am J Physiol; 1990 Aug; 259(2 Pt 1):G300-5. PubMed ID: 2166441
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The role of prostaglandins in the development of cardio- and hemodynamic disorders in postischemic shock].
    Sagach VF, Zhukova AV.
    Fiziol Zh (1978); 1991 Aug; 37(2):25-31. PubMed ID: 1905243
    [Abstract] [Full Text] [Related]

  • 9. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock.
    Mózes T, Braquet P, Filep J.
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R872-7. PubMed ID: 2802004
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021.
    Touvay C, Vilain B, Taylor JE, Etienne A, Braquet P.
    Prog Lipid Res; 1986 Oct; 25(1-4):277-88. PubMed ID: 2827186
    [No Abstract] [Full Text] [Related]

  • 12. Role of PAF and cytokines in microvascular tissue injury.
    Koltai M, Hosford D, Braquet P.
    J Lab Clin Med; 1992 May; 119(5):461-6. PubMed ID: 1316420
    [No Abstract] [Full Text] [Related]

  • 13. Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats.
    Sirén AL, Feuerstein G.
    Am J Physiol; 1989 Jul; 257(1 Pt 2):H25-32. PubMed ID: 2546449
    [Abstract] [Full Text] [Related]

  • 14. Role of platelet-activating factor in hepatocellular Ca2+ alterations during hemorrhagic shock.
    Silomon M, Pizanis A, Larsen R, Rose S.
    J Surg Res; 1997 Oct; 72(2):101-6. PubMed ID: 9356229
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog.
    Filep J, Hermán F, Braquet P, Mózes T.
    Biochem Biophys Res Commun; 1989 Jan 31; 158(2):353-9. PubMed ID: 2916986
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recent progress in ginkgolide research.
    Braquet P, Esanu A, Buisine E, Hosford D, Broquet C, Koltai M.
    Med Res Rev; 1991 May 31; 11(3):295-355. PubMed ID: 1647474
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.